S2Medical Investor Relations Material
Latest events
Q2 2025
22 Aug, 2025
Q4 2024
21 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from S2Medical
Access all reports
S2Medical AB is a Swedish medical technology company specializing in wound care solutions, particularly for burns and chronic wounds. The company develops, produces, and markets a range of innovative products that cover the entire wound healing process. Their portfolio includes INSTAQRETT, a sterile single-use mechanical debridement tool, and the Epiprotect line, which features synthetic substitutes for allografts and xenografts, ulcer dressings, and blood-stilling membranes. Additionally, they distribute Silverlon antimicrobial dressings in the Nordic countries and operate the S2Clinic, a wound healing center in Sweden. The company is headquartered in Linköping, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
S2M
Country
🇸🇪 Sweden